Cargando…
Nuclear factor-κB inhibitor Bay11-7082 inhibits gastric cancer cell proliferation by inhibiting Gli1 expression
Dysregulated nuclear factor (NF)-κB signaling pathway is involved in gastric carcinogenesis. The present study aimed to investigate the antitumor effects of the NF-κB inhibitor, Bay11-7082, on gastric cancer (GC) and elucidate its underlying molecular mechanisms. The MTT assay was performed to asses...
Autores principales: | Yan, Yan, Qian, Heya, Cao, Ying, Zhu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905653/ https://www.ncbi.nlm.nih.gov/pubmed/33732377 http://dx.doi.org/10.3892/ol.2021.12562 |
Ejemplares similares
-
Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082
por: Zhang, Lingyu, et al.
Publicado: (2019) -
Effects of the NF-κB Signaling Pathway Inhibitor BAY11-7082 in the Replication of ASFV
por: Gao, Qi, et al.
Publicado: (2022) -
The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells
por: Hu, Shuiqing, et al.
Publicado: (2012) -
The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2013) -
In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri
por: Debnath, Anjan, et al.
Publicado: (2018)